Results 191 to 200 of about 248,562 (312)
Prediction model for extrathyroidal extension in thyroid papillary carcinoma based on ultrasound radiomics. [PDF]
Yuan SS +9 more
europepmc +1 more source
Metastasis of <i>in situ</i> solid papillary carcinoma of the breast to the lungs:a rare case report. [PDF]
Zhou J, Wu M, Huang X, Liu K, Xu J.
europepmc +1 more source
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley +1 more source
The occurrence of hyperthyroidism after thermal ablation for thyroid papillary carcinoma: a retrospective multicentre observational study. [PDF]
Xie R +14 more
europepmc +1 more source
Neuroimmune alterations and nociceptive behavior in oral carcinogenesis in rats
Abstract Oral cancer pain is a frequent and debilitating symptom associated with tumor progression. Although neuronal mechanisms have been extensively studied, the role of immune and glial cells in the trigeminal nociceptive pathway remains poorly understood.
Joana Maria dos Santos Alves +7 more
wiley +1 more source
Differential expression profiles of immunoregulatory genes in anaplastic thyroid carcinomas with a coexistent papillary carcinoma component. [PDF]
Orlando G +7 more
europepmc +1 more source
ABSTRACT Objective This systematic review evaluated oral health, including oral health‐related quality of life (OHRQoL), in older adults with head and neck cancer (HANC) or oral potentially malignant disorders (OPMDs). The PICO/PECO focus question for this study was: ‘What is the incidence/prevalence of adverse oral health (O) among people aged 60 ...
Ciaran Moore +5 more
wiley +1 more source
Clinical and imaging characteristics of encapsulated papillary carcinoma: a comparative analysis with intraductal papilloma. [PDF]
Liu ZL +6 more
europepmc +1 more source
This study assessed the 2022 WHO classification for predicting RAIR disease in thyroid carcinomas, comparing it to older classifications. In a retrospective study of 253 cases, we found the 2022 classification more effective, especially by identifying high‐grade carcinomas and tumour necrosis as critical predictive factors.
Elise André +10 more
wiley +1 more source

